Noncommercial Presence vs. Permanent Establishment: How to Stay on the Right Side of the Line
On 17 June, REVERA Law Group invites pharmaceutical companies to a business breakfast on permanent establishments and monitoring the presence of foreign companies.
The event is closed‑door.
During the meeting, REVERA Law Group experts will outline practical steps on:
1. how to determine the boundary between a non‑commercial presence and a permanent establishment,
2. which indicators regulatory authorities monitor, and
3. how to safely structure a presence model.
Registration
Why We Are Holding This Meeting
REVERA works with foreign pharmaceutical companies in Belarus and understands the dynamics of the pharmaceutical market. We have observed that some representative offices operate under models which, if they breach the restrictions on commercial activity, create real tax risks and risks for local management.
About the Event
What This Breakfast Will Cover
The Belarusian pharmaceutical market operates under long‑standing norms: the concept of a representative office of a foreign company is a familiar form of commercial presence. Tax authorities increasingly identify signs of a permanent establishment, although such cases often arise outside the pharmaceutical sector. Nevertheless, there are a number of situations in pharma where a presence has been recognised as a permanent establishment, which can lead to significant fiscal and compliance consequences.
This business breakfast is not a public seminar. It is an opportunity for a focused discussion on real market dynamics, sector‑specific compliance challenges, and actionable steps attendees can take now.
Who Should Attend
- A select circle of representatives from foreign companies active in the Belarusian pharmaceutical market,
- Participants who want to calmly discuss sector specifics and strategies for mitigating permanent establishment risks.
Why This Is Relevant
- It allows participants to analyse the real market situation, including the specific characteristics of the pharmaceutical sector.
- It addresses concrete risks: tax risks and risks for local management arising from non‑compliance with restrictions on commercial activity.
- The event is held in a confidential format, ensuring honest and open experience-sharing.
Key Takeaways for Participants
Attendees will leave with:
- an understanding of the differences between non‑commercial presence and permanent establishment in practice,
- clear indicators that regulatory bodies scrutinise,
- a practical self‑assessment checklist for commercial presence models,
- options ranging from preventive compliance measures to structural changes when a model requires remediation, and
- the opportunity to discuss individual situations with REVERA experts.